Загрузка...
Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
The advancement of cancer immunotherapy faces barriers which limit its efficacy. These include weak immunogenicity of the tumor, as well as immunosuppressive mechanisms which prevent effective antitumor immune responses. Recent studies suggest that aberrant expression of cancer testis antigens (CTAs...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3477552/ https://ncbi.nlm.nih.gov/pubmed/23097673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/760965 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|